These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 8005812

  • 1. Combined-modality therapy of esophageal cancer with radiotherapy, etanidazole, and cisplatin-fluorouracil, with or without surgery: neurotoxicity, other toxicities and outcome.
    Buswell L, Recht A, Clark J, Ravikumar T, Busse PM, Coleman CN.
    Int J Radiat Oncol Biol Phys; 1994 Jun 15; 29(3):535-40. PubMed ID: 8005812
    [Abstract] [Full Text] [Related]

  • 2. Combined-modality therapy for esophageal cancer: phase I trial of escalating doses of paclitaxel in combination with cisplatin, 5-fluorouracil, and high-dose radiation before esophagectomy.
    Weiner LM, Colarusso P, Goldberg M, Dresler C, Coia LR.
    Semin Oncol; 1997 Dec 15; 24(6 Suppl 19):S19-93-S19-95. PubMed ID: 9427276
    [Abstract] [Full Text] [Related]

  • 3. Phase I-II study of 5-fluorouracil, recombinant interferon alpha2a, and cisplatin in combination with external beam radiation therapy followed by surgery in patients with locally advanced carcinoma of the esophagus.
    Damle S, Beitler JJ, Haynes H, Camacho M, Wolf E, Wadler S.
    Am J Clin Oncol; 1999 Aug 15; 22(4):391-5. PubMed ID: 10440197
    [Abstract] [Full Text] [Related]

  • 4. A phase II trial of interferon alpha-2A, 5-fluorouracil, and cisplatin in patients with advanced esophageal carcinoma.
    Ilson DH, Sirott M, Saltz L, Heelan R, Huang Y, Keresztes R, Kelsen DP.
    Cancer; 1995 May 01; 75(9):2197-202. PubMed ID: 7712428
    [Abstract] [Full Text] [Related]

  • 5. Intervention with the hypoxic tumor cell sensitizer etanidazole in the combined modality treatment of limited stage small-cell lung cancer. A one-institution study.
    Urtasun RC, Palmer M, Kinney B, Belch A, Hewitt J, Hanson J.
    Int J Radiat Oncol Biol Phys; 1998 Jan 15; 40(2):337-42. PubMed ID: 9457818
    [Abstract] [Full Text] [Related]

  • 6. Pilot study of local hyperthermia, radiation therapy, etanidazole, and cisplatin for advanced superficial tumours.
    Bornstein BA, Herman TS, Hansen JL, Buswell L, Zouranjian PS, Fraser SM, Teicher BA, Svensson GK, Coleman CN.
    Int J Hyperthermia; 1995 Jan 15; 11(4):489-99. PubMed ID: 7594803
    [Abstract] [Full Text] [Related]

  • 7. Concurrent chemoradiotherapy for esophageal cancer: comparison between intermittent standard-dose cisplatin with 5-fluorouracil and daily low-dose cisplatin with continuous infusion of 5-fluorouracil.
    Sai H, Mitsumori M, Yamauchi C, Araki N, Okumura S, Nagata Y, Nishimura Y, Hiraoka M.
    Int J Clin Oncol; 2004 Jun 15; 9(3):149-53. PubMed ID: 15221597
    [Abstract] [Full Text] [Related]

  • 8. [Comparison between docetaxel plus cisplatin and cisplatin plus fluorouracil in the neoadjuvant chemoradiotherapy for local advanced esophageal squamous cell carcinoma].
    Wu S, Chen MY, Luo JC, Wei L, Chen Z.
    Zhonghua Zhong Liu Za Zhi; 2012 Nov 15; 34(11):873-6. PubMed ID: 23291141
    [Abstract] [Full Text] [Related]

  • 9. Phase II feasibility study of preoperative concurrent chemoradiotherapy with cisplatin plus 5-fluorouracil and elective lymph node irradiation for clinical stage II/III esophageal squamous cell carcinoma.
    Hashimoto J, Kato K, Ito Y, Kojima T, Akimoto T, Daiko H, Hamamoto Y, Matsushita H, Katano S, Hara H, Tanaka Y, Saito Y, Nagashima K, Igaki H.
    Int J Clin Oncol; 2019 Jan 15; 24(1):60-67. PubMed ID: 30109544
    [Abstract] [Full Text] [Related]

  • 10. Phase II trial of paclitaxel, fluorouracil, and cisplatin in patients with advanced carcinoma of the esophagus.
    Ilson DH, Ajani J, Bhalla K, Forastiere A, Huang Y, Patel P, Martin L, Donegan J, Pazdur R, Reed C, Kelsen DP.
    J Clin Oncol; 1998 May 15; 16(5):1826-34. PubMed ID: 9586897
    [Abstract] [Full Text] [Related]

  • 11. Preoperative combined modality therapy with paclitaxel, carboplatin, prolonged infusion 5-fluorouracil, and radiation therapy in localized esophageal cancer: preliminary results of a Minnie Pearl Cancer Research Network phase II trial.
    Meluch AA, Hainsworth JD, Gray JR, Thomas M, Whitworth PL, Davis JL, Greco FA.
    Cancer J Sci Am; 1999 May 15; 5(2):84-91. PubMed ID: 10198730
    [Abstract] [Full Text] [Related]

  • 12. A retrospective comparison of neoadjuvant chemoradiotherapy regimens for locally advanced esophageal cancer.
    Sanford NN, Catalano PJ, Enzinger PC, King BL, Bueno R, Martin NE, Hong TS, Wo JY, Mamon HJ.
    Dis Esophagus; 2017 Jul 01; 30(7):1-8. PubMed ID: 28475728
    [Abstract] [Full Text] [Related]

  • 13. Phase III study comparing cisplatin plus fluorouracil to paclitaxel, cisplatin, and fluorouracil induction chemotherapy followed by chemoradiotherapy in locally advanced head and neck cancer.
    Hitt R, López-Pousa A, Martínez-Trufero J, Escrig V, Carles J, Rizo A, Isla D, Vega ME, Martí JL, Lobo F, Pastor P, Valentí V, Belón J, Sánchez MA, Chaib C, Pallarés C, Antón A, Cervantes A, Paz-Ares L, Cortés-Funes H.
    J Clin Oncol; 2005 Dec 01; 23(34):8636-45. PubMed ID: 16275937
    [Abstract] [Full Text] [Related]

  • 14. A prospective, multicenter phase I/II study of induction chemotherapy with docetaxel, cisplatin and fluorouracil (DCF) followed by chemoradiotherapy in patients with unresectable locally advanced esophageal carcinoma.
    Satake H, Tahara M, Mochizuki S, Kato K, Hara H, Yokota T, Kiyota N, Kii T, Chin K, Zenda S, Kojima T, Bando H, Yamazaki T, Iwasa S, Honma Y, Hamauchi S, Tsushima T, Ohtsu A.
    Cancer Chemother Pharmacol; 2016 Jul 01; 78(1):91-9. PubMed ID: 27193097
    [Abstract] [Full Text] [Related]

  • 15. Mature survival results with preoperative cisplatin, protracted infusion 5-fluorouracil, and 44-Gy radiotherapy for esophageal cancer.
    Kleinberg L, Knisely JP, Heitmiller R, Zahurak M, Salem R, Burtness B, Heath EI, Forastiere AA.
    Int J Radiat Oncol Biol Phys; 2003 Jun 01; 56(2):328-34. PubMed ID: 12738305
    [Abstract] [Full Text] [Related]

  • 16. Phase II study of docetaxel and cisplatin chemotherapy in 5-fluorouracil/cisplatin pretreated esophageal cancer.
    Shim HJ, Cho SH, Hwang JE, Bae WK, Song SY, Cho SB, Lee WS, Joo YE, Na KJ, Chung IJ.
    Am J Clin Oncol; 2010 Dec 01; 33(6):624-8. PubMed ID: 20142726
    [Abstract] [Full Text] [Related]

  • 17. Toxicity data for preoperative concurrent chemoradiotherapy with oxaliplatin and continuous infusion 5-fluorouracil for locally advanced esophageal cancer.
    Thukral A, Metz J, Hwang WT, O'Dwyer P, Plastaras J, Both S, Bar-Ad V.
    Dis Esophagus; 2011 Jul 01; 24(5):330-6. PubMed ID: 21143694
    [Abstract] [Full Text] [Related]

  • 18. Toxicity, response rates and survival outcomes of induction cisplatin and irinotecan followed by concurrent cisplatin, irinotecan and radiotherapy for locally advanced esophageal cancer.
    Watkins JM, Zauls AJ, Kearney PL, Shirai K, Ruppert BN, Harper JL, Sherman CA, Aguero EG, Reed CE, Sharma AK.
    Jpn J Clin Oncol; 2011 Mar 01; 41(3):334-42. PubMed ID: 21084436
    [Abstract] [Full Text] [Related]

  • 19. Long-term outcome of phase II trial evaluating chemotherapy, chemoradiotherapy, and surgery for locoregionally advanced esophageal cancer.
    Swisher SG, Ajani JA, Komaki R, Nesbitt JC, Correa AM, Cox JD, Lahoti S, Martin F, Putnam JB, Smythe WR, Vaporciyan AA, Walsh GL, Roth JA.
    Int J Radiat Oncol Biol Phys; 2003 Sep 01; 57(1):120-7. PubMed ID: 12909224
    [Abstract] [Full Text] [Related]

  • 20. Use of concurrent chemotherapy, accelerated fractionation radiation, and surgery for patients with esophageal carcinoma.
    Adelstein DJ, Rice TW, Becker M, Larto MA, Kirby TJ, Koka A, Tefft M, Zuccaro G.
    Cancer; 1997 Sep 15; 80(6):1011-20. PubMed ID: 9305700
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.